Genotyping Plasmodium vivax isolates from the 2011 outbreak in Greece

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Spanakos, Gregory ^a,b   Alifrangis, Michael ^c,d   Schousboe, Mette L ^c,d   Patsoula, Eleni ^b   Tegos, Nicholas ^b   Hansson, Helle H ^c,d   Bygbjerg, Ib C ^c,d   Vakalis, Nicholas C ^b   Tseroni, Maria ^a   Kremastinou, Jenny ^a   Hadjichristodoulou, Christos ^e  

^a Hellenic Centre for Diseases Control and Prevention   (Greece)

^b NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Mental Health Center Glostrup   (Denmark)

^e UNIVERSITY OF THESSALY   (Greece)

Author keywords

Genotyping; Greece; Merozoite surface protein 3; Microsatellites; Outbreak; Plasmodium vivax

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; BLOOD SAMPLING; DISEASE TRANSMISSION; EPIDEMIC; GENETIC POLYMORPHISM; GENOTYPE; GREECE; HAPLOTYPE; HUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA;

ANTIGENS, PROTOZOAN; DISEASE OUTBREAKS; GREECE; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; PROTOZOAN PROTEINS; SEASONS;

EID: 84891000957     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-463     Document Type: Article

References (46)

1. WHO, World Malaria Report 2012 Geneva: World Health Organization 2012 http://www.who.int/malaria/publications/world-malaria-report-2012/ wmr2012-full-report.pdf.
2. The international limits and population at risk of Plasmodium vivax transmission in 2009. Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI, PLoS Negl Trop Dis 2010 4 774 10.1371/journal.pntd.0000774 20689816
3. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo H, Lancet Infect Dis 2009 9 555 566 10.1016/S1473-3099(09)70177-X 19695492
4. The global public health significance of Plasmodium vivax. Battle KE, Gething PW, Elyazar IR, Moyes CL, Sinka ME, Howes RE, Guerra CA, Price RN, Baird KJ, Hay SI, Adv Parasitol 2012 80 1 111 23199486
5. The global distribution and population at risk of malaria: past, present, and future. Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW, Lancet Infect Dis 2004 4 327 336 10.1016/S1473-3099(04)01043-6 15172341
6. The neglected burden of Plasmodium vivax malaria. Mendis K, Sina BJ, Marchesini P, Carter R, Am J Trop Med Hyg 2001 64 97 106 11425182
7. The decline of malaria in Finland-the impact of the vector and social variables. Hulden L, Hulden L, Malar J 2009 8 94 10.1186/1475-2875-8-94 19422702
8. The present state of malaria in the world. Russell PF, Am J Trop Med 1953 32 111 123
9. Evolutionary and historical aspects of the burden of malaria. Carter R, Mendis KN, Clin Microbiol Rev 2002 15 564 594 10.1128/CMR.15.4.564-594.2002 12364370
10. WHO, World Malaria Report 2011 Geneva: World Health Organization 2011 http://apps.who.int/iris/bitstream/10665/44792/2/9789241564403-eng-full.pdf
11. ECDC, Consultation on Plasmodium Vivax Transmission Risk in Europe. Stockholm, 17-18 January 2012 Meeting Report. http://www.ecdc.europa.eu/en/ publications/Publications/MER-Malaria-meeting.pdf
12. Could malaria reappear in Italy? Romi R, Sabatinelli G, Majori G, Emerg Infect Dis 2001 7 915 919 10.3201/eid0706.010601 11747716
13. Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. Gautret P, Cramer JP, Field V, Caumes E, Jensenius M, Gkrania-Klotsas E, de Vries PJ, Grobusch MP, Lopez-Velez R, Castelli F, Schlagenhauf P, Hervius Askling H, von Sonnenburg F, Lalloo DG, Loutan L, Rapp C, Basto F, Santos O'Connor F, Weld L, Parola P, EuroTravNet Network, Euro Surveill 2012 17 ii=20205
14. Migration and malaria in Europe. Monge-Maillo B, López- Vélez R, Mediterr J Hematol Infect Dis 2012 4 2012014 22536477
15. Malaria in Greece, 1975 to 2010. Vakali A, Patsoula E, Spanakos G, Danis K, Vassalou E, Tegos N, Economopoulou A, Baka A, Pavli A, Koutis C, Hadjichristodoulou C, Kremastinou T, Euro Surveill 2012 17 ii=20322
16. HCDCP, Epidemiological Surveillance Report Malaria, 2011 (01/01/2011-31/12/2011) http://www.keelpno.gr/Portals/0/Malaria-Report-EN-2011 12 31.pdf
17. Greece: illegal immigration in the midst of crisis. Kasimis C, 2012 http://www.migrationinformation.org/Profiles/display.cfm?ID=884
18. An annotated checklist and bibliography of the mosquitoes of Greece (Diptera: Culicidae). Samanidou-Voyadjoglou A, Darsie RF Jr, Mosq Syst 1993 25 177 185
19. Molecular characterization of the anopheles maculipennis complex during surveillance for the 2004 Olympic games in Athens. Patsoula E, Samanidou-Voyadjoglou A, Spanakos G, Kremastinou J, Nasioulas G, Vakalis NC, Med Vet Entomol 2007 21 36 43 10.1111/j.1365-2915.2007.00669.x 17373945
20. Bruce-Chwatt LJ, Draper CC, World Health Organization (WHO) Regional Office for Europe, Some Aspects of Malaria Eradication in Greece Report on a mission to Greece Geneva: WHO 1974
21. The genetic diversity of Plasmodium vivax-a review. de Souza-Neiras WC, de Melo LM, Machado RL, Mem Inst Oswaldo Cruz 2007 102 245 254 17568928
22. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NP, Anderson TJ, White NJ, J Infect Dis 2007 195 927 933 10.1086/512241 17330781
23. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Karunaweera ND, Ferreira MU, Munasinghe A, Barnwell JW, Collins WE, King CL, Kawamoto F, Hartl DL, Wirth DF, Gene 2008 410 105 112 10.1016/j.gene.2007.11.022 18226474
24. Fourteen polymorphic microsatellite DNA markers for the human malaria parasite Plasmodium vivax. Karunaweera ND, Ferreira MU, Hartl DL, Wirth DF, Mol Ecol Notes 2006 7 172 175 10.1111/j.1471-8286.2006.01534.x
25. Meager genetic variability of the human malaria agent Plasmodium vivax. Leclerc MC, Durand P, Gauthier C, Patot S, Billotte N, Menegon M, Severini C, Ayala FJ, Renaud F, Proc Natl Acad Sci USA 2004 101 14455 14460 10.1073/pnas.0405186101 15328406
26. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Imwong M, Nair S, Pukrittayakamee S, Sudimack D, Williams JT, Mayxay M, Newton PN, Kim JR, Nandy A, Osorio L, Carlton JM, White NJ, Day NP, Anderson TJ, Int J Parasitol 2007 37 1013 1022 10.1016/j.ijpara.2007.02.010 17442318
27. A single step, PCR-based method for the detection and differentiation of Plasmodium vivax and P. falciparum. Patsoula E, Spanakos G, Sofianatou D, Parara M, Vakalis N, Ann Trop Med Parasitol 2003 97 15 21 10.1179/000349803125002535 12662418
28. Polymorphism at the merozoite surface protein-3 locus of Plasmodium vivax: global and local diversity. Bruce MC, Galinski MR, Barnwell JW, Snounou G, Day KP, Am J Trop Med Hyg 1999 61 518 525 10548283
29. Entomologic and molecular investigation into Plasmodium vivax transmission in Singapore, 2009. Ng LC, Lee KS, Tan CH, Ooi PL, Lam-Phua SG, Lin R, Pang SC, Lai YL, Solhan S, Chan PP, Wong KY, Ho ST, Vythilingam I, Malar J 2010 9 305 10.1186/1475-2875-9-305 21029478
30. Current status of vivax malaria among civilians in Korea. Lee JS, Kho WG, Lee HW, Seo M, Lee WJ, Korean J Parasitol 1998 36 241 248 10.3347/kjp.1998.36. 4.241 9868889
31. Malaria in Maremma, Italy. Baldari M, Tamburro A, Sabatinelli G, Romi R, Severini C, Cuccagna P, Fiorilli G, Allegri MP, Buriani C, Toti M, Lancet 1998 351 1246 1247 10.1016/S0140-6736(97)10312-9 9643745
32. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Armengaud A, Legros F, Quatresous I, Barre H, Valayer P, Fanton Y, D'Ortenzio E, Schaffner F, Euro Surveill 2006 11 ii=3081
33. First autochthonous malaria case due to Plasmodium vivax since eradication, Spain, October 2010. Santa-Olalla Peralta P, Vazquez-Torres MC, Latorre-Fandos E, Mairal-Claver P, Cortina-Solano P, Puy-Azón A, Adiego Sancho B, Leitmeyer K, Lucientes-Curdi J, Sierra-Moros MJ, Euro Surveill 2010 15 ii=19684
34. A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece-a re-emerging infection in the southern borders of Europe? Andriopoulos P, Economopoulou A, Spanakos G, Assimakopoulos G, Int J Infect Dis 2013 17 125 e128 10.1016/j.ijid.2012.09.009 23098813
35. Merozoite surface protein-3alpha is a reliable marker for population genetic analysis of Plasmodium vivax. Zakeri S, Barjesteh H, Djadid ND, Malar J 2006 5 53 10.1186/1475-2875-5-53 16817951
36. Allelic dimorphism in the merozoite surface protein-3 in Korean isolates of Plasmodium vivax. Han ET, Song TE, Park JH, Shin EH, Guk SM, Kim TY, Chai JY, Am J Trop Med Hyg 2004 71 745 749 15642964
37. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, Parasitology 2000 121 257 272 10.1017/S0031182099006356 11085246
38. Genetic diversity and multiple infections of Plasmodium vivax malaria in western Thailand. Cui L, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, Zhou GChen H, Yan G, Sattabongkot J, Am J Trop Med Hyg 2003 68 613 619 12812356
39. Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials. Koepfli C, Mueller I, Marfurt J, Goroti M, Sie A, Oa O, Genton B, Beck HP, Felger I, J Infect Dis 2009 199 1074 1080 10.1086/597303 19275476
40. Analysis of polymorphisms in the merozoite surface protein-3 gene and two microsatellite loci in Sri Lankan Plasmodium vivax: evidence of population substructure in Sri Lanka. Schousboe ML, Rajakaruna RS, Amerasinghe PH, Flemming Konradsen F, Ord R, Pearce R, Bygbjerg IC, Roper C, Alifrangis M, Am J Trop Med Hyg 2011 85 994 1001 10.4269/ajtmh.2011.11-0338 22144433
41. Polymorphism in the Plasmodium vivax msp 3 gene in field samples from Tierralta, Colombia. Cristiano FA, Pérez MA, Nicholls RS, Guerra AP, Mem Inst Oswaldo Cruz 2008 103 493 496 10.1590/S0074-02762008000500015 18797765
42. Genetic diversity of Plasmodium vivax malaria in China and Myanmar. Zhong D, Bonizzoni M, Zhou G, Wang G, Chen B, Vardo-Zalik A, Cui L, Yan G, Zheng B, Infect Genet Evol 2011 11 1419 1425 10.1016/j.meegid.2011.05.009 21624503
43. Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers. Zakeri S, Raeisi A, Afsharpad M, Kakar Q, Ghasemi F, Atta H, Zamani G, Memon MS, Salehi M, Djadid ND, Parasitol Int 2010 59 15 21 10.1016/j.parint. 2009.06.006 19545647
44. Autochthonous Plasmodium vivax malaria in a Greek schoolgirl of the Attica region. Loupa CV, Tzanetou K, Kotsantis I, Panopoulos S, Lelekis M, Malar J 2012 11 52 10.1186/1475-2875-11-52 22353879
45. Autochthonous Plasmodium vivax malaria in Greece, 2011. Danis K, Baka A, Lenglet A, Van Bortel W, Terzaki I, Tseroni M, Detsis M, Papanikolaou E, Balaska A, Gewehr S, Dougas G, Sideroglou T, Economopoulou A, Vakalis N, Tsiodras S, Bonovas S, Kremastinou J, Euro Surveill 2011 6 ii=19993
46. Epidemiological Surveillance Report, Malaria in Greece 2012 http://www.keelpno.gr/Portals/0/Files/English files/Malaria reports/Malaria Report-2012-FINAL-23-82013-EN.pdf